AI-Designed Vaccine Enters Human Trials: What Cambridge Found
University of Cambridge researchers have completed the first human trial of a vaccine whose key component is an artificial intelligence designed entirely. The Phase I study, published in the Journal of Infection, tested the AI-designed antigen in 39 people and found it generated a modest immune response with no significant safety concerns. The vaccine targets […]
English 






















































































































































































































































































































































































